221 related articles for article (PubMed ID: 35053539)
1. The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts.
Stanganelli I; Spagnolo F; Argenziano G; Ascierto PA; Bassetto F; Bossi P; Donato V; Massi D; Massone C; Patuzzo R; Pellacani G; Quaglino P; Queirolo P; Zalaudek I; Palmieri G; On Behalf Of Italian Melanoma Intergroup Imi
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053539
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma.
Boutros A; Cecchi F; Tanda ET; Croce E; Gili R; Arecco L; Spagnolo F; Queirolo P
Front Oncol; 2021; 11():733917. PubMed ID: 34513710
[TBL] [Abstract][Full Text] [Related]
3. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
4. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
[TBL] [Abstract][Full Text] [Related]
5. Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors.
Jansen P; Lodde GC; Wetter A; Welt A; Stuschke M; Dührsen U; Stoffels I; Klode J; Livingstone E; Zimmer L; Roesch A; Hadaschik E; Griewank KG; Schadendorf D; Ugurel S
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():41-44. PubMed ID: 34855243
[TBL] [Abstract][Full Text] [Related]
6. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
7. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
8. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Hernández-Guerrero T; Doger B; Moreno V
Drugs Today (Barc); 2019 Aug; 55(8):485-494. PubMed ID: 31461085
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.
Fania L; Didona D; Di Pietro FR; Verkhovskaia S; Morese R; Paolino G; Donati M; Ricci F; Coco V; Ricci F; Candi E; Abeni D; Dellambra E
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33572373
[TBL] [Abstract][Full Text] [Related]
11. Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma.
García-Foncillas J; Tejera-Vaquerizo A; Sanmartín O; Rojo F; Mestre J; Martín S; Azinovic I; Mesía R
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158897
[TBL] [Abstract][Full Text] [Related]
12. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma.
Benzaquen M
Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547
[TBL] [Abstract][Full Text] [Related]
13. PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma.
Yakobson A; Abu Jama A; Abu Saleh O; Michlin R; Shalata W
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627069
[TBL] [Abstract][Full Text] [Related]
14. [The Cutaneous Squamous Cell Carcinoma - An Update].
Burda B; Schultz ES
Laryngorhinootologie; 2023 Oct; 102(10):735-741. PubMed ID: 37054747
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives.
Alberti A; Bossi P
Front Oncol; 2021; 11():727027. PubMed ID: 35070956
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
Queirolo P; Cinquini M; Argenziano G; Bassetto F; Bossi P; Boutros A; Clemente C; de Giorgi V; Del Vecchio M; Patuzzo R; Pennachioli E; Peris K; Quaglino P; Reali A; Zalaudek I; Spagnolo F
ESMO Open; 2024 May; 9(5):103005. PubMed ID: 38688192
[TBL] [Abstract][Full Text] [Related]
17. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.
Ogata D; Tsuchida T
Curr Treat Options Oncol; 2019 Mar; 20(4):30. PubMed ID: 30874952
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Unresectable Cutaneous Squamous Cell Carcinoma with Cemiplimab in a Patient on Dialysis.
Grace de Lima S; Hyrcza MD; Monzon JG
Case Rep Oncol; 2023; 16(1):137-142. PubMed ID: 36880029
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K; Tsai KK
Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
[TBL] [Abstract][Full Text] [Related]
20. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma.
Ahmed SR; Petersen E; Patel R; Migden MR
Expert Rev Clin Pharmacol; 2019 Oct; 12(10):947-951. PubMed ID: 31524530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
